Thyroid eye disease (TED) presents with a broad and heterogeneous constellation of ocular and periocular signs and symptoms. These manifestations are the result of the underlying autoimmune ...

—Even long after the active phase of thyroid eye disease has subsided, a multitude of challenging quality-of-life issues may persist. Several recent studies have established that the physical ...

Although there’s no cure for thyroid eye disease (TED), effective treatments and lifestyle changes can help you manage symptoms, such as double vision, eye pain, and dry, irritated eyes. These ...

(Reuters) -Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to become the ...

Doses of Tepezza are given by an intravenous infusion through a blood vessel in your arm. This infusion is usually given at a hospital, health care provider’s office, or infusion center. Sometimes you ...

If you're one of the one million Americans diagnosed with thyroid eye disease this year, odds are you're plagued by irritated eyes, puffiness, light sensitivity or other bothers. The good news? There ...

As mentioned in Overview, most thyroid eye disease (TED) cases are closely related to hyperthyroidism. Approximately 85% of patients with TED develop the disease around 18 months before or after the ...

Nearly 2 years after their final infusion with the IGF-IR inhibitor teprotumumab (Tepezza), 82% of patients with thyroid eye disease did not need further treatment for their symptoms, revealed ...

CHICAGO — Endocrinologists should consider ways to refine their in-clinic eye exams for patients with thyroid eye disease, including testing for color vision, visual acuity, pupillary reaction, and ...

Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024 ...